SLNO Soleno Therapeutics Inc.

Filed as SOLENO THERAPEUTICS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

In 2026 Q2 Eric Khrom sold out of Soleno Therapeutics.

Who owns SLNO

Sorted by value, long equity only, as of 2026 Q2.

					History
Eric Khrom, Khrom Capital Management exited 2026 Q2 Last 2026 Q1	4.6%	Exit −4.63%	1,511,481	$51M	History

0 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

13Fs that reported it each quarter. Click a bar for that quarter’s holders.